Clinical and Nonclinical Disposition and In Vitro Drug-Drug Interaction Potential of Felcisetrag, a Highly Selective and Potent 5-HT4 Receptor Agonist

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2107-0180

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Clinical and Nonclinical Disposition and In Vitro Drug-Drug Interaction Potential of Felcisetrag, a Highly Selective and Potent 5-HT4 Receptor Agonist ; volume:47 ; number:3 ; day:14 ; month:2 ; year:2022 ; pages:371-386 ; date:5.2022
European journal of drug metabolism and pharmacokinetics ; 47, Heft 3 (14.2.2022), 371-386, 5.2022

Creator: Pusalkar, Sandeepraj
Chowdhury, Swapan K.
Czerniak, Richard
Zhu, Xiaochun
Li, Yuexian
Balani, Suresh K.
Ramsden, Diane

Contributor: SpringerLink (Online service)

DOI: 10.1007/s13318-021-00751-8

URN: urn:nbn:de:101:1-2022071006211090468055

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:31 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Pusalkar, Sandeepraj
Chowdhury, Swapan K.
Czerniak, Richard
Zhu, Xiaochun
Li, Yuexian
Balani, Suresh K.
Ramsden, Diane
SpringerLink (Online service)

Other Objects (12)

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Evaluation of drug-drug interaction of lusutrombopag, a thrombopoietin receptor agonist, via metabolic enzymes and transporters

Evaluating drug-drug interaction information in NDF-RT and DrugBank

Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications

Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine

Modelling and simulation techniques to investigate pharmacokinetics, pharmacodynamics, and drug-drug interactions

A Review of Daclatasvir Drug–Drug Interactions

Drug–Drug Interactions with Direct Oral Anticoagulants

Extracting drug-drug interactions from biomedical texts

Multi-view feature representation and fusion for drug-drug interactions prediction

Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Evaluation of drug-drug interaction of lusutrombopag, a thrombopoietin receptor agonist, via metabolic enzymes and transporters

Evaluating drug-drug interaction information in NDF-RT and DrugBank

Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications

Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine

Modelling and simulation techniques to investigate pharmacokinetics, pharmacodynamics, and drug-drug interactions

A Review of Daclatasvir Drug–Drug Interactions

Drug–Drug Interactions with Direct Oral Anticoagulants

Extracting drug-drug interactions from biomedical texts

Multi-view feature representation and fusion for drug-drug interactions prediction

Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Evaluation of drug-drug interaction of lusutrombopag, a thrombopoietin receptor agonist, via metabolic enzymes and transporters

Evaluating drug-drug interaction information in NDF-RT and DrugBank

Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications

Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine

Modelling and simulation techniques to investigate pharmacokinetics, pharmacodynamics, and drug-drug interactions

A Review of Daclatasvir Drug–Drug Interactions

Drug–Drug Interactions with Direct Oral Anticoagulants

Extracting drug-drug interactions from biomedical texts

Multi-view feature representation and fusion for drug-drug interactions prediction

Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Clinical and Nonclinical Disposition and In Vitro Drug-Drug Interaction Potential of Felcisetrag, a Highly Selective and Potent 5-HT4 Receptor Agonist

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Evaluation of drug-drug interaction of lusutrombopag, a thrombopoietin receptor agonist, via metabolic enzymes and transporters

Evaluating drug-drug interaction information in NDF-RT and DrugBank

Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications

Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine

Modelling and simulation techniques to investigate pharmacokinetics, pharmacodynamics, and drug-drug interactions

A Review of Daclatasvir Drug–Drug Interactions

Drug–Drug Interactions with Direct Oral Anticoagulants

Extracting drug-drug interactions from biomedical texts

Multi-view feature representation and fusion for drug-drug interactions prediction

Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Evaluation of drug-drug interaction of lusutrombopag, a thrombopoietin receptor agonist, via metabolic enzymes and transporters

Evaluating drug-drug interaction information in NDF-RT and DrugBank

Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications

Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine

Modelling and simulation techniques to investigate pharmacokinetics, pharmacodynamics, and drug-drug interactions

A Review of Daclatasvir Drug–Drug Interactions

Drug–Drug Interactions with Direct Oral Anticoagulants

Extracting drug-drug interactions from biomedical texts

Multi-view feature representation and fusion for drug-drug interactions prediction

Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Evaluation of drug-drug interaction of lusutrombopag, a thrombopoietin receptor agonist, via metabolic enzymes and transporters

Evaluating drug-drug interaction information in NDF-RT and DrugBank

Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications

Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine

Modelling and simulation techniques to investigate pharmacokinetics, pharmacodynamics, and drug-drug interactions

A Review of Daclatasvir Drug–Drug Interactions

Drug–Drug Interactions with Direct Oral Anticoagulants

Extracting drug-drug interactions from biomedical texts

Multi-view feature representation and fusion for drug-drug interactions prediction

Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

Related objects

Reset password